XML 72 R58.htm IDEA: XBRL DOCUMENT v3.24.4
Segment reporting (Details)
$ in Millions
3 Months Ended
Nov. 30, 2024
USD ($)
segment
Nov. 30, 2023
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 3  
Segment Reporting Information [Line Items]    
Sales $ 39,459 $ 36,707
Adjusted operating income (Non-GAAP measure) 593 687
Footprint optimization (333) 0
Acquisition-related amortization (269) (275)
Acquisition and disposition-related costs (104) (163)
Adjustments to equity earnings in Cencora (76) (50)
Certain legal and regulatory accruals and settlements (59) (82)
LIFO provision (12) (48)
Transformational cost management 15 (109)
Operating loss (245) (39)
Reportable Segments | U.S. Retail Pharmacy    
Segment Reporting Information [Line Items]    
Sales 30,866 28,944
Adjusted operating income (Non-GAAP measure) 441 694
Reportable Segments | International    
Segment Reporting Information [Line Items]    
Sales 6,425 5,832
Adjusted operating income (Non-GAAP measure) 168 142
Reportable Segments | U.S. Healthcare    
Segment Reporting Information [Line Items]    
Sales 2,172 1,931
Adjusted operating income (Non-GAAP measure) 25 (96)
Reportable Segments | Pharmacy | U.S. Retail Pharmacy    
Segment Reporting Information [Line Items]    
Sales 24,711 22,384
Reportable Segments | Pharmacy | International    
Segment Reporting Information [Line Items]    
Sales 912 926
Reportable Segments | Retail | U.S. Retail Pharmacy    
Segment Reporting Information [Line Items]    
Sales 6,155 6,560
Reportable Segments | Retail | International    
Segment Reporting Information [Line Items]    
Sales 2,117 1,932
Reportable Segments | Wholesale | International    
Segment Reporting Information [Line Items]    
Sales 3,397 2,974
Corporate and Other    
Segment Reporting Information [Line Items]    
Sales (4) 0
Adjusted operating income (Non-GAAP measure) $ (41) $ (53)